Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

adriamycin aglycone

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2004
Highly Cited
2004
SummaryThe pharmacokinetics and metabolism of doxorubicin (DX) and epirubicin (epiDX) were investigated in eight cancer patients… Expand
  • table 1
2004
2004
SummaryA specific, sensitive and reliable HPLC method for the determination of doxorubicin (DX), epirubicin (epiDX) and their… Expand
  • table 1
  • figure 1
  • table 2
2004
2004
SummaryThe effect of tumor cell density on the cellular pharmacokinetics of doxorubicin (DXR) and cisplatin (CDDP) was studied… Expand
  • figure 1
  • figure 2
  • figure 4
  • figure 3
Highly Cited
1997
Highly Cited
1997
The knowledge about molecular factors driving simple ligand-DNA interactions is still limited. The aim of the present study was… Expand
1996
1996
7-O-(2,6-Dideoxy-6,6,6-trifluoro-alpha-L-lyxo-hexopyranosyl)adriam ycinone (3), whose substituent at C-5' is a lipophilic… Expand
Highly Cited
1980
Highly Cited
1980
The concentration of adriamycin and its metabolites in serum and tissues was determined by high-performance liquid chromatography… Expand
1978
1978
The syntheses of several 13-deoxyanthracyclines are described. Koenigs-Knorr condensation of epsilon-rhodomycinone (12) with the… Expand
1976
1976
Adriamycin inhibits the succinoxidase system and the NADH-oxidase system. Both of the intact mitocondrial enzymes and the pentane… Expand
  • table 1
  • table 3
  • table 2
  • table 4
  • table 6
Highly Cited
1975
Highly Cited
1975
The synthesis of 4'-epi-daunorubicin and of 4'-epi-adriamycin was performed by condensation of 2,3,6-trideoxy-3… Expand